Avrobio Inc (DELISTED) (AVRO:DL)
16.80
-0.24
(-1.41%)
USD |
NASDAQ |
Jun 20, 16:00
Avrobio Total Liabilities (Quarterly): 3.509M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.509M |
December 31, 2023 | 6.354M |
September 30, 2023 | 7.664M |
June 30, 2023 | 11.80M |
March 31, 2023 | 30.01M |
December 31, 2022 | 28.58M |
September 30, 2022 | 31.41M |
June 30, 2022 | 27.90M |
March 31, 2022 | 32.18M |
December 31, 2021 | 34.36M |
September 30, 2021 | 22.88M |
June 30, 2021 | 17.10M |
March 31, 2021 | 12.98M |
Date | Value |
---|---|
December 31, 2020 | 16.89M |
September 30, 2020 | 25.38M |
June 30, 2020 | 15.78M |
March 31, 2020 | 13.20M |
December 31, 2019 | 14.50M |
September 30, 2019 | 10.44M |
June 30, 2019 | 9.355M |
March 31, 2019 | 10.58M |
December 31, 2018 | 11.30M |
September 30, 2018 | 6.163M |
June 30, 2018 | 10.41M |
March 31, 2018 | 6.18M |
December 31, 2017 | 30.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.509M
Minimum
Mar 2024
34.36M
Maximum
Dec 2021
19.10M
Average
16.89M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
Agenus Inc | 446.88M |
BioCryst Pharmaceuticals Inc | 944.06M |
AIM ImmunoTech Inc | 11.36M |
Protalix BioTherapeutics Inc | 60.04M |
Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 92.35M |
Shareholders Equity (Quarterly) | 88.84M |